跳至主要内容
临床试验/NCT05185219
NCT05185219招募中不适用

The Effect of Valerian on Insomnia in Menopausal Women: Randomized Placebo-controlled Trial

China Medical University Hospital1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2021年12月14日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
入组人数
100
试验地点
1
主要终点
Sleep quallity

研究概览

简要总结

Menopausal women often complain that it is difficult to fall asleep and easy to wake up at night and early in the morning and it is in the middle of night difficult to fall asleep again. If the above symptoms persist for at least three months and occur at least three times a week, plus the impact on daytime work and rest, and meet the International Classification of Sleep Disorders (ICSD-3) )'S s "Insomnia" diagnostic criteria. According to statistics, 30% to 60% of women face sleep disorders during menopause.

详细描述

The investigators expect to receive outpatient admissions in the hospital attached to China Medical University. Menopausal women aged 45-60 years old who have been diagnosed with insomnia who meet criteria of International Classification of Sleep Disorders (ICSD-3) will be randomly assigned for clinical trials. Patients will take two Valerian capsules (1000mg/day) per day for four weeks. Pittsburgh Sleep Index (PSQI) will be used to evaluate subjective sleep quality. TCM patterns will be evaluated by three physicians of TCM gynecology independently before and after taking Valeriana. The data will conduct a biological analysis to compare the difference in sleep quality between the trial group and the control group.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
45 Years 至 60 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • 45〜60 years old, and is menopaused for at least 1 year。
  • meet the criteria of ICSD-3 for insomnia

排除标准

  • psychiatry disease
  • Heart, brain, liver diseases
  • Insomnia is caused by diseases.
  • Steroid used within 6 months
  • pregnant or breastfeeding

研究组 & 干预措施

Valerian

Experimental

generic name: XIE CAO CONC dosage form: capsule dosage: 500 mg/capsule, 6 capsules a day frequency: 3 times a day after each meal, 2 capsules each time duration: 30 days

干预措施: Valerian (Drug)

Control

Placebo Comparator

generic name: placebo (Caramel Colors dyed starch) dosage form: capsule dosage: 500 mg/capsule, 6 capsules a day frequency: 3 times a day after each meal, 2 capsules each time duration: 30 days

干预措施: Valerian (Drug)

结局指标

主要结局

Sleep quallity

时间窗: 30 days

Sleep quality will be evaluated by Pittsburgh Sleep Index (PSQI). The sum of the scores on PSQI ranges from 0 to 21, and higher scores mean a worse outcome.

次要结局

  • Traditional Chinese medicine (TCM) constitution(30 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Shan-Yu Su

Director

China Medical University Hospital

研究点 (1)

Loading locations...

相似试验